Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Proqr Therapeutics (NQ: PRQR )

0.7456 +0.0053 (+0.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 339,143
Open 0.7300
Bid (Size) 0.7250 (4)
Ask (Size) 0.7800 (15)
Prev. Close 0.7403
Today's Range 0.7300 - 0.7650
52wk Range 0.5300 - 9.090
Shares Outstanding 71,290,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga

Performance

YTD
-90.77%
-90.77%
1 Month
-4.18%
-4.18%
3 Month
-5.68%
-5.68%
6 Month
-20.48%
-20.48%
1 Year
-90.12%
-90.12%

More News

Read More
This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing
Via Benzinga
Expert Ratings for ProQR Therapeutics
Via Benzinga
Where ProQR Therapeutics Stands With Analysts
Via Benzinga
ProQR Therapeutics Pulls Plug On Inherited Retinal Disease Programs, Cuts 30% Workforce
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Via Benzinga
Where ProQR Therapeutics Stands With Analysts
Via Benzinga
Mid-Afternoon Market Update: US Stocks Extend Losses; Dow Tumbles 450 Points
Via Benzinga
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
78 Biggest Movers From Friday
Via Benzinga
Mid-Morning Market Update: Markets Open Higher As Dow Rises Over 100 Points
Via Benzinga
52 Weeks High And Low Article
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.